REQUEST A DEMO
Total
USD $0.00
Search more companies

Fresenius Kabi Oncology Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Fresenius Kabi Oncology Limited Profile Updated: November 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Fresenius Kabi Oncology Limited is an unlisted company, incorporated on 18/03/2003. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24231DL2003PLC119441 and registration number is 119441. The company is a manufacturing, professional, scientific and technical company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, scientific research and development.

Headquarters
Echelon Institutional Area Plot No-11 Sector - 32 Gurgaon In-Hr In 122001
Gurgaon; Haryana; Postal Code: 122001

Contact Details: Purchase the Fresenius Kabi Oncology Limited report to view the information.

Basic Information
Total Employees:
Purchase the Fresenius Kabi Oncology Limited report to view the information.
Outstanding Shares:
Purchase the Fresenius Kabi Oncology Limited report to view the information.
Registered Capital:
Purchase the Fresenius Kabi Oncology Limited report to view the information.
Financial Auditors:
Purchase the Fresenius Kabi Oncology Limited report to view the information.
Incorporation Date:
March 18, 2003
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Whole Time Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Dabur Pharma ( Thailand ) Co.Ltd.
Fresenius Kabi Oncology Inc USA
Fresenius Kabi Oncology Plc.UK
Company Performance
Financial values in the chart are available after Fresenius Kabi Oncology Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
9.66%
Total operating revenue
7.77%
Operating profit (EBIT)
33.56%
EBITDA
21.24%
Net Profit (Loss) for the Period
19.67%
Total assets
2.38%
Total equity
4.34%
Operating Profit Margin (ROS)
1.65%
Net Profit Margin
0.57%
Return on Equity (ROE)
0.52%
Debt to Equity Ratio
-0.05%
Quick Ratio
-0.21%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?